Nu Skin Enterprises (NYSE:NUS) Releases FY 2019 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) updated its FY 2019 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $3.20-3.35 for the period, compared to the Thomson Reuters consensus estimate of $3.95. The company issued revenue guidance of $2.48-2.52 billion, compared to the consensus revenue estimate of $2.77 billion.Nu Skin Enterprises also updated its Q2 2019 guidance to $0.82-0.84 EPS.

NUS has been the topic of several research reports. Zacks Investment Research lowered shares of Inflarx from a buy rating to a hold rating in a report on Friday, May 3rd. Deutsche Bank lowered shares of Hilton Hotels from a buy rating to a hold rating and set a $92.60 price target on the stock. in a report on Wednesday, May 1st. They noted that the move was a valuation call. ValuEngine upgraded shares of Valmont Industries from a sell rating to a hold rating in a report on Friday. Bank of America cut their price target on shares of Canopy Growth from $80.00 to $75.00 and set a buy rating on the stock in a report on Wednesday, June 19th. Finally, Stifel Nicolaus set a $99.00 price target on shares of C.H. Robinson Worldwide and gave the company a hold rating in a report on Monday, March 25th. Three research analysts have rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of $73.13.

Shares of NUS traded up $1.48 during mid-day trading on Tuesday, reaching $45.51. 409,975 shares of the stock traded hands, compared to its average volume of 653,478. Nu Skin Enterprises has a 12-month low of $43.57 and a 12-month high of $88.68. The company has a current ratio of 1.86, a quick ratio of 1.10 and a debt-to-equity ratio of 0.44. The stock has a market cap of $2.48 billion, a price-to-earnings ratio of 12.93, a price-to-earnings-growth ratio of 1.03 and a beta of 0.74. The firm has a fifty day moving average of $48.16.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Tuesday, April 30th. The company reported $0.77 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.06. The firm had revenue of $623.60 million during the quarter, compared to the consensus estimate of $615.98 million. Nu Skin Enterprises had a net margin of 4.82% and a return on equity of 26.81%. The firm’s revenue was up 1.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.79 earnings per share. As a group, research analysts predict that Nu Skin Enterprises will post 3.92 earnings per share for the current year.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Featured Article: What is cost of equity?

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with's FREE daily email newsletter.